INTRODUCTION
Few would dispute the necessity to study cellular Ca2l movements -indeed, in higher organisms, changes in cytosolic free [Ca2+] are a vital physiological event from the very beginning of life at the moment of fertilization, to its very end at the final beat of the heart. These changes are brought about either as a result of mobilizing intracellular Ca2+ or as a result of inflow of the ion from the extracellular medium. The means by which cells control Ca2+ fluxes, and particularly Ca21 inflow, is increasingly becoming a focus of attention. Changes in intracellular [Ca2+] , especially that following Ca2+ inflow across the cell membrane induced by a range of different stimuli, are the trigger not only in the shortterm but also in the long-term of many vital physiological responses in cells in a range of tissues and species. Moreover, aberrant control of Ca2+ fluxes appears to be associated with many pathological situations.
During the past decade in particular, a large number of articles have been published about many aspects of cellular Ca2+ fluxes: about the discovery and generation of the new second messenger Ins(1,4,5)P3 and of the related enzymic reactions that generate and dispose of it; about the range of agonists able to induce changes in cellular Ca2+ fluxes; about the cellular compartments that appear to contain agonist-sensitive Ca2+ pools; about the continual development of new techniques to measure and locate the ion within cells; and about how 'cross-talk' between second messenger systems, such as those generating cyclic AMP and Ins(1,4,5)P3 for instance, are able to induce/modulate Ca2+ fluxes. Numerous offerings and ideas have in turn evolved from these studies as to the nature of the mechanisms involved in the control of cell Ca2+. The aim of this article is to contribute further to this knowledge by integrating a number of relevant observations and reports obtained over the years by numerous investigators and to synthesize a general scheme that we hope will be useful in the current debates about the control of cellular Ca2+ fluxes. We focus on liver tissue, drawing upon the large body of information available about such fluxes derived from studies from both single cells (hepatocytes) and the intact organ (perfused liver). We also focus particularly on the issue of how glucagon (and cyclic AMP) might regulate/modulate Ca2+ fluxes induced by calcium-mobilizing agonists. This is an aspect of the control of Ca2+ fluxes in liver that is not only important in many aspects of liver function, but also one that we believe holds clues as to the mechanism ofhormone-induced Ca2+ inflow and outflow in this tissue.
BRIEF HISTORY OF RELEVANT EVENTS Ringer (1883) and Heilbrunn (1952) were among the first to recognize the ubiquitous role of Ca2+ in physiological events. Features of their work were later extended by others who envisaged the ion as having a regulatory role in cell metabolism (Lehninger, 1950; Bygrave, 1966 Bygrave, , 1967 Gevers and Krebs, 1966; Rasmussen, 1970) . During the 1970s, the numerous studies on cellular Ca2+ fluxes were confined largely to movements across the membranes of isolated organelles, in particular those of the mitochondria and endoplasmic reticulum (e.g. Lehninger et al., 1967; Bygrave, 1978a; Williamson et al., 1981; Akerman and Nicholls, 1983) . Initially, little attention was paid to the possible role of hormones in the control of these intracellular events, but towards the end of that decade a realization emerged that certain hormones and also cyclic AMP might play a role in the control of intracellular Ca2+ (Bygrave, 1978a; Rasmussen, 1981; Borle, 1981 ; Exton, 1981) . Others were advocating a possible controlling role of cyclic AMP in Ca2+ fluxes across the cell (plasma) membrane (Friedmann and Park, 1968; Borle, 1972) and that Ca2+ and cyclic AMP could have an interactive role in the control of cell metabolism (Rasmussen and Barrett, 1984) .
A further significant landmark occurred towards the end of the 1970s. This was the realization that cyclic AMP generation and action (Robison et al., 1971 ) on their own could not account for the mechanism by which a-adrenergic agonists, vasopressin and angiotensin induce metabolic events such as glycogenolysis; the evidence was mounting that Ca2+ was involved in some (at that time unknown) way (Van de Werve et al., 1977; Assimacopoulos-Jeanett et al., 1977; Keppens and de Wulfe, 1977 ; reviewed by Exton, 1981 Exton, , 1985 Exton, , 1988 . In studies quite separate, but which were later to be very relevant to this subject, knowledge was being obtained about the role of Ca2+ in the hydrolysis of phosphatidylinositol (Michell, 1975) . The role of Ins(1,4,5)P3 as second messenger in the action of Ca2+-mobilizing agonists was reviewed by Berridge (1987) , and the fascinating story of the concepts leading up to it is outlined by Michell (1992) .
During the 1980s a number of reports appeared in which the general question was raised as to whether glucagon (or cyclic AMP) was itself able to induce cellular Ca2+ fluxes in isolated organelles, in intact cells or in the perfused rat liver. In many instances the responses induced by glucagon were compared with those induced by Ca2+-mobilizing hormones which, it was realized early on, are far more potent than glucagon in their ability to mobilize Ca2+. However, what a number ofthose reports revealed, and others continue to reveal, is that glucagon is able to exert effects in liver such that the Ca2+ flux-inducing action of Ca2+-mobilizing agonists is greatly modified. It is this aspect, the means by which glucagon is able to modify the action of Ca2+-mobilizing agonists, that this review primarily addresses.
First, we briefly review the patterns of Ca2+ inflow and outflow induced by Ca2+-mobilizing agonists that occur in the perfused rat liver and in hepatocytes, and where possible we integrate information gained from each of the two experimental systems. Tsien et al., 1982) . Although other intracellular probes are available (see, e.g., Borle and Snowdowne, 1986) , the fluorescent indicators quin2 and more recently fura2 have been used by most researchers to measure intracellular free Ca2+ in hepatocytes, largely on account of their ease of handling and non-invasive properties. The application of these indicators has provided an important step forward in enabling a further understanding of the effects of a-agonists and glucagon on Ca2+ fluxes in cells. As implied above, the two principal experimental systems that have contributed to our current understanding of cellular Ca2+ fluxes in liver are the perfused rat liver and single cells (hepatocytes) prepared therefrom. While each system inherently has particular advantages and disadvantages (see Exton, 1975; Berry et al., 1991) Graf et al. (1987) .
One serious limitation to the study of Ca2+ fluxes in the perfused rat liver has been the inability to date to directly monitor changes in intracellular [Ca2+] . Some success in perfused heart has been achieved, however, using intracellular indicators (Levine et al., 1990) . On the other hand, qualitative information about the extent to which these changes occur can be gauged from the appearance of glucose (from glycogen breakdown) in the medium, particularly following alterations to the extracellular [Ca2+] (see Reinhart et al., 1984b) Figure 2 . Here, changes in perfusate Ca , Cross-talk in liver between glucagon and Ca2+-mobilizing agonists (a) Phenylephrine ;j~~~~~~.
-. and Reinhart et al. (1982) , Altin and Bygrave (1986) and Benedetti et al. (1989) . See Graf et al. (1987) Reinhart et al., 1984b) , the response can be rapidly re-activated by providing an excess of Ca2+ to the perfusate medium.
Sustained responses are equally rapid in onset but once the maximum is attained, little or no decay is observed. Clearly these responses are dependent on Ca2+ inflow from the extracellular medium. As will be shown later in this review, much of this information is able to be obtained also with hepatocytes. Stimulation of oxygen uptake by Ca2+-mobilizing agonists (see, e.g., Figure 2c ) most probably reflects movement of Ca2+ into the mitochondria which then stimulates enzymes of the citrate cycle (see, e.g., Denton and McCormack, 1985 Park (1968), Friedmann (1972) , Friedmann and Dambach (1973) and Kraus-Friedmann (1986) , and has since been confirmed in other laboratories (e.g. Morgan et al., 1985; Altin and Bygrave, 1986; Rashed and Patel, 1987; Benedetti et al., 1989) . Where examined, the effects of glucagon could be reproduced when dibutyryl cyclic AMP was the agonist. The amount of Ca2+ released, however, and the rate of release are much less than that mobilized by phenylephrine, vasopressin or angiotensin; these glucagon-induced responses appear to be increased substantially when the extracellular [Ca2+] is lowered (Benedetti et al., 1989 (EGF) (Altin and Bygrave, 1987a) and by phosphatidic acid and arachidonic acid (Altin and Bygrave, 1987b) . Preadministration of glucagon to the perfused rat liver was shown to also suppress the oscillations induced by vasopressin alluded to above (Graf et al., 1987) . Earlier Jenkinson and Koller (1977) had shown that the combined addition of al-and 8-agonists increased synergistically the efflux of 45Ca from liver slices of the guinea pig. Similar findings were made by Cocks et al. (1984) .
A major effect of pre-administered glucagon is to significantly attenuate the initial Ca2' efflux induced by these agonists. Its other major effect is to greatly accelerate Ca2+ influx. The magnitude of this synergistic effect on Ca2+ influx is dependent on the period of preincubation; maximal effects in the perfused rat liver system are seen after approx. 4 min of preincubation. An important observation relating to the issue of the possible mechanisms involved, however, is that while co-administration of glucagon with the Ca2+-mobilizing agonists does not influence the extent of efflux induced by the agonists alone, glucagon still enhances Ca2+ inflow to a considerable extent (Altin and Bygrave, 1986) . This indicates that the effects of glucagon in the perfused rat liver are virtually immediate and that its earliest effects are on Ca2+ inflow and later, either directly or indirectly as a consequence of some presently unknown action, on Ca2+ outflow. As mentioned above, the effects of glucagon on agonist-induced inflow are not observed when the extracellular [Ca2+] is relatively low (Benedetti et al., 1989) , similar to the action of vaspressin alone on Ca2+ inflow also mentioned above. Glucagon will, however, promote Ca2+ inflow induced by a second pulse of vasopressin if the extracellular [Ca2+] is above approx. 500 ,uM. These experiments thus reveal that, despite the hormone regime under study, the Ca2+ gradient across the plasma membrane is a significant factor determining whether the synergistic effects of glucagon with Ca2+-mobilizing agonists on Ca2+ inflow will (or will not) be manifest. In the perfused liver the acceleration of Ca2+ influx seen with vasopressin and angiotensin in these conditions is much greater than that seen with phenylephrine. A number of the features described above of the effect of glucagon on vasopressininduced Ca2+ fluxes in the perfused rat liver are illustrated in Figure 3 .
The information in Figure 3 reveals another important aspect about the massive Ca2+ influx induced by the synergistic effects of the two hormones. That is, despite the very large amount of Cross-talk in liver between glucagon and Ca2+-mobilizing agonists 5 the ion taken up by the liver, there is no sign of damage having occurred, at least over the time course of the experiment. This is reflected in the fact that a second administration of the hormones at 74 min into the perfusion will produce a second response only slightly less than the first.
In summarizing to this point, several features are evident. The first is that glucagon alone is able to induce a small but significant outflow of Ca2+ from the perfused rat liver. Secondly, the onset of this outflow follows a short lag period, and the magnitude of it is less than that resulting from the action of Ca2+-mobilizing agonists. Thirdly, glucagon-induced Ca2+ outflow appears to increase as the extracellular [Ca2+] is decreased. Finally, the major effect of glucagon in the perfused rat liver is (a) when coadministered with Ca2+-mobilizing agonists, to immediately promote Ca2+ inflow without altering Ca2+ outflow, (b) when administered before Ca2+-mobilizing agonists, to attenuate the ability of oc-agonists to promote Ca2+ outflow, and (c) to greatly augment the ability of these agonists to promote Ca2+ inflow.
STUDIES ON Ca2`FLUXES IN HEPATOCYTES INDUCED BY Ca2+-MOBILIZING AGONISTS
As pointed out by Crofts and Barritt (1989) and Berry et al. (1991) , accurate measurement of rates of hormone-stimulated Ca2+ inflow in hepatocytes has proved difficult. The main methods employed to measure rates of Ca2+ inflow are the use of 45Ca under steady-state conditions (see Barritt et al., 1981) , (indirect) measurement of increases in intracellular Ca2+ using fluorescent indicators following the addition of Ca2+ to a medium containing negligible Ca2 , measurement of the rates of quenching of fluorescence of intracellular quin2 following Mn2+ addition (see, e.g., Crofts and Barritt, 1990) , and measurement of the initial rate of activation of glycogen phosphorylase following the addition of Ca2+ to a medium containing negligible Ca2+. A further complication to studies of Ca2+ inflow is that there is mounting evidence that more than one system facilitates Ca2+ entry in the plasma membrane of liver cells (Barritt et al., 1981; Hughes et al., 1986; Altin and Bygrave, 1987a; Barritt and Hughes, 1991; Llopis et al., 1992) . The potentially useful technique of patch-clamping appears to be technically difficult in liver plasma membranes (see, e.g., Sawanobori et al., 1989; Barritt and Hughes, 1991) .
These potential complications may in large part account for some of the apparent discrepancies between groups on the characteristics of Ca2+ inflow in hepatocytes. For instance, Crofts and Barritt (1989) found that vasopressin-induced Ca2+ inflow measured in quin2-loaded cells exhibits a biphasic curve as the extracellular [Ca2+] is increased; the second phase showed no signs of saturation even at 5 mM Ca2+. By contrast, the data of Mauger et al. (1984) and Joseph et al. (1985) showed Ca2+ inflow induced by noradrenaline, vasopressin and angiotensin to be saturated at 1-2 mM external Ca2 . Mauger et al. (1985) also showed that glucagon alone can stimulate the initial rate of Ca2+ inflow.
Both the basal and hormone-stimulated Ca2+ inflow systems exhibit a broad specificity for bivalent metal ions (Crofts and Barritt, 1990) , with Mn2+, Co2+, Ni2+ and Zn2+ all able to quench the fluorescence of Ca-quin2 loaded into hepatocytes.
As intimated above, a serious drawback to studies with the perfused rat liver has been the inability to (Charest et al., 1985a) . (2) Glucagon alone is also able to induce an increase in intracellular [Ca2+] . However, the time of onset lags by some 10 s and the rapidity and magnitude of the change are not quite as great (Charest et al., 1983 ; see also Mauger and Claret, 1986 Studies on single hepatocytes (see, e.g., Woods et al., 1986 Woods et al., , 1987 have shown that Ca2+-mobilizing hormones induce oscillations in intracellular Ca2 , the frequency of which depends on the agonist concentration. It is of interest that in this single-cell system the responses to vasopressin are different from those to phenylephrine , as in the intact perfused rat liver (Altin and Bygrave, 1985 ; see Figure 1 ).
EFFECTS OF GLUCAGON OR OF DIBUTYRYL CYCLIC AMP ON Ca2+ FLUXES IN HEPATOCYTES INDUCED BY Ca2+-MOBILIZING AGONISTS
As intimated above, glucagon alone appears able to induce an increase in intracellular [Ca2+] as well as having a number of other Ca2+-flux-related effects in hepatocytes. It is able to increase 45Ca movement into hepatocytes , but Studer et al. (1984) report that glucagon at physiological concentrations has no effect on intracellular [Ca2+] . The interesting observation of Assimacoupoulus-Jeanett et al. (1982) and Morgan et al. (1983) that increases in dibutyryl cyclic AMP are able to reverse vasopressin-induced Ca2+ mobilization (see also Crane et al., 1982) appears to be consistent with the finding (Keppens and De Wulf, 1984) that vasopressin inhibits the maintenance of cyclic AMP levels in hepatocytes by activating phosphodiesterase. Charest et al. (1985b) have shown that glucagon is able to potentiate Ca2+ inflow induced by extracellular ATP.
In kinetic studies of the influence of glucagon on 45Ca inflow induced by Ca2+-mobilizing agonists, Mauger et al. (1985) and Poggioli et al. (1986) reported that co-addition of glucagon with vasopressin greatly stimulated Ca2+ inflow. The dose-response curves for either glucagon or vasopressin were unaffected by the other agent, i.e. the EC-5 did not change but the maximal effects of each were enhanced. The effects of glucagon were seen also with dibutyryl cyclic AMP. These workers concluded that both hormones were activating the same gating mechanism. Burgess et al. (1986) , using guinea pig hepatocytes, showed that the fl-adrenoceptor agonist isoprenaline alone induced Ca2+ efflux when the extracellular [Ca2+] was low but not when it was high. They also observed a significant potentiation by this agent of angiotensin-induced Ca2+ mobilization. They suggested that the interacting effects did not involve steps subsequent to the generation of signals by angiotensin. Because there appeared to be no apparent increase in the total intracellular pool size induced by isoprenaline, it was concluded that the agonist may have increased the sensitivity of the endoplasmic reticular pool to Ins(1,4,5)P3. Studies by Kass et al. (1990) on Mn2+ inflow showed that glucagon alone had no effect on Mn2+ inflow but that its prior administration to hepatocytes enhanced vasopressin-induced Mn2+ inflow and abolished the latency period observed between vasopressin addition and the onset of Mn2+ uptake. The effects of glucagon could be mimicked by dibutyryl cyclic AMP. Crofts and Barritt (1990) , however, provided evidence that the effects of co-addition of glucagon and vasopressin on Mn2+-induced quenching were the same as the sum of their individual effects.
The oscillations in intracellular [Ca2+] induced by vasopressin or phenylephrine mentioned earlier are also able to be modulated by elevated levels of intracellular cyclic AMP induced by glucagon, dibutyryl cyclic AMP or forskolin (Somogyi et al., 1992; ; see also Capiod et al., 1991) . While the elevated cyclic AMP does not itself induce the oscillations, it enhances both the peak free Ca2+ and the frequency more with differences seen between the effects of elevated cyclic AMP levels on Ca2" fluxes in the perfused rat liver (Altin and Bygrave, 1986;  Figure 3) , the effects on vasopressin-induced spikes are different to those induced by phenylephrine; they do not affect peak free Ca2+ but induce an eventual fall in spiking frequency . Of additional interest is the finding of Somogyi et al. (1992) that protein kinase C activation by diacylglycerol, generated together with Ins(1,4,5)P3 during phosphatidylinositol breakdown, inhibits the cytoplasmic Ca2+ oscillations.
There is a feature of the synergism between glucagon and Ca2+-mobilizing hormones that appears to have been neglected from the experimental viewpoint, yet may hold clues to the mechanism(s) involved. Some years ago, Blackmore et al. (1984) reported that when the pH of the incubation is increased to values near 8, the ability of glucagon and Ca2+-mobilizing agonists to increase hepatocyte cell Ca2+ is greatly enhanced. Indeed, at this pH, glucagon appeared to be a more potent Ca2+-mobilizing agonist than vasopressin, adrenaline or angiotensin. These findings were observed also in the perfused rat liver (Altin and Bygrave, 1987a) , where direct measurements of the synergism (as described in Figure 3) Barritt, 1992) . This enables a 'cycling' of the ion between the two compartments into and out of which it is moving. It has been suggested, following the principles of substrate cycling laid down earlier by Newsholme and Crabtree (1976) , that this form of control may be important in the regulation of Ca2+ fluxes induced by hormones as discussed here (Bygrave, 1978a,b) . This has obvious implications for the regulation of metabolic processes in different cell compartments that are sensitive to Ca2+ (Bygrave, 1967; Rasmussen, 1981) . In this context it is relevant to consider whether Ca2+ cycling across the plasma membrane might be altered by the action of hormones, not only on Ca2+ inflow mechanisms but also on the Ca2+-ATPase.
It has been reported that the purified Ca2+-ATPase is inhibited by the action in vitro of glucagon (Lotersztajn et al., 1981 (Lotersztajn et al., , 1985 Lin et al., 1983 ) and more recently it has been suggested that the Ca2+-ATPase is coupled to a Gs-like protein (Lotersztajn et al., 1992; Jouneaux et al., 1993 By combining the Ca2+-electrode and 45Ca techniques in the perfused rat liver, Reinhart et al. (1984c) were able to show that net Ca2+ fluxes across the plasma membrane could be described in terms of the activities of a Ca2+ cycle comprising separate Ca2+ inflow and outflow components. The al-adrenergic agonists phenylephrine, vasopressin and angiotensin were found to stimulate both inflow and outflow in a time-dependent manner; the latter occurring before the former. By comparison, glucagon had a relatively small but significant effect in this study. As mentioned above, Altin and Bygrave (1986) observed that following coadministration of glucagon and vasopressin to perfused rat livers, Ca2+ outflow was unaffected but Ca2+ inflow was greatly enhanced. Finally, and again using the Ca2+-electrode and 45Ca techniques, Altin and Bygrave (1987c) were able to demonstrate in the perfused rat liver that the main effect of these hormones was to activate a Ca2+ inflow pathway rather than to inhibit Ca2+ outflow via the Ca2+-ATPase. On the other hand, a recent study has concluded that dibutyryl cyclic AMP stimulates Ca2+ efflux in rat hepatocytes (F. L. Bygrave, A. Gamberucci, R. Fulceri, R. Giunti and A. Benedetti, unpublished work).
Thus the extent to which hormones, particularly glucagon, activate the plasma membrane Ca2+-ATPase appears to remain a debatable issue. Clarification of the possible role of G proteins in Ca2+-ATPase activity is needed (see Jouneaux et al., 1993) . We also should not lose sight of the fact that the high sensitivity of the Ca2+-ATPase to intracellular [Ca2+] (see Lotersztajn et al., 1981) , independent of any hormone action, is likely to be a prevailing factor determining Ca2+ outflow in liver.
DOES GLUCAGON EMPTY THE (Ca2+-MOBILIZING) AGONIST-SENSITIVE INTRACELLULAR Ca2+ STORES?
Mechanisms by which Ca2+ entry might be evoked in nonexcitable cells in general have been considered recently by Irvine (1992) [see also Putney (1990) and Neher (1992) ]; the general issue will not be elaborated upon here. What is clear from these considerations, however, is that Ca2+ entry appears to be able to be controlled to some (possibly quite large) degree by the extent to which intracellular Ca2+ stores themselves are empty or full. Presumably the greater the extent of emptying of these stores, the greater the potential ability to exert a positive effect on plasma membrane Ca2+ inflow. In the present context, the question arises as to whether evidence exists linking glucagon action to the emptying (or refilling) of these stores and whether this purported action has any bearing on altering intracellular [Ca2+].
Studies with both hepatocytes and the perfused rat liver have provided evidence that glucagon releases Ca2+ from the same intracellular stores as does vasopressin. Combettes et al. (1986) Combettes et al. (1986) concluded that glucagon accelerates the fast phase of vasopressin-induced inflow and elevates the final internal store as that affected by vasopressin, and (b) potentiating the inflow of external Ca2+ induced by vasopressin. In a related study, Mauger and Claret (1986) showed that glucagon mobilizes Ca2+ from a pool that is also sensitive to the action of Ca2+-mobilizing agonists. Kass et al. (1990) , examining Mn2+ inflow into hepatocytes, showed that prior emptying of the endoplasmic reticular store with the inhibitor of endoplasmic reticular Ca2+ inflow 2,5-di-(tert-butyl)-1,4,-benzohydroquinone enhanced the action of glucagon or of dibutyryl cyclic AMP on vasopressin-induced Mn2+ inflow. Of additional interest was their finding that the effects of glucagon on vasopressin-induced Mn2+ inflow were unaffected by membrane depolarization and by pertussis toxin treatment.
Several reports from studies with the perfused rat liver following the sequential administration of the agonists provide evidence that glucagon mobilizes Ca2+ from the same store as that mobilized by phenylephrine (Reinhart et al., 1982) or by vasopressin Kraus-Friedmann, 1986; Mine et al., 1988a; Benedetti et al., 1989) .
Related to these issues is the question of which intracellular store the Ca2+ enters as a result of the synergistic action of glucagon and Ca2+-mobilizing agonists on hepatocytes and the perfused rat liver as discussed above. The studies of Morgan et al. (1985) provided evidence that mitochondria were the intracellular site into which this Ca2+ enters. The evidence was based on both invasive analyses of the mitochondrial Ca2+ content following hormonal treatment of hepatocytes and noninvasive analyses of Ca2+ movements following treatment of intact hepatocytes with specific inhibitors of mitochondrial energy transduction.
In a study examining the influence of vasopressin and/or glucagon on mitochondrial Ca2+ and Ca2+-sensitive oxidative enzymes in the perfused rat liver, Assimacopoulos-Jeannet et al. (1986) also showed that these hormones additively induce increases in intramitochondrial [Ca2+] . This was reflected also in the stimulation of the activities of pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase.
In agreement with these conclusions, Altin and Bygrave (1986) rapidly isolated mitochondria and endoplasmic reticulum from the perfused rat liver following co-administration of glucagon with Ca2+-mobilizing agonists. Their data revealed an accumulation of Ca2+ into the subsequently isolated organelles, particularly mitochondria, although significant increases in the endoplasmic reticulum-enriched fraction also were evident. Although considerable care was taken in those studies to minimize post-isolation Ca2+ redistribution (see Reinhart et al., 1984a) , it is possible that some redistribution did take place especially involving Ca2+ release from the microsomes and its reuptake into the mitochondria. Benedetti et al. (1989) , for example, have found that lowering the temperature to approx. 4 'C, as occurs in the course of the invasive organellar isolation technique, induces a rapid efflux of Ca2+ from the microsomes that could move into mitochondria which readily take up Ca2+ at these temperatures Banhegyi et al., 1991) . Banhegyi et al. (1991) have shown that a non-invasive technique using hepatocytes provided evidence that it is a non-mitochondrial pool into which the bulk of the Ca2+ enters following co-administration of glucagon and vasopressin. It is significant however that, at low temperatures, the majority of the Ca2+ entered the mitochondria (Banhegyi et al., 1991) . In this regard Assimacopoulos-Jeannet et al. (1986) reported that, provided Na+ is kept to a minimum and the mitochondria are maintained in ice-cold media, the (mitochondrial) preparation remains stable intracellular [Ca2"] attained, by (a) releasing Ca2+ from the same for the duration of the isolation procedure.
F. L. Bygrave and A. Benedetti Kleineke and Soling (1985) concluded from a non-invasive study of perfused rat liver that the endoplasmic reticulum and not the mitochondria is the hormone-sensitive intracellular store. Further evidence for a reticular component for Ca2+ deposition is the observation that destruction of the endoplasmic reticulum with bromotrichloromethane prevented the synergistic accumulation of Ca2+ by perfused rat liver (Benedetti et al., 1989) . Bond et al. (1987) had previously examined this issue by employing electron probe analyses of the intact liver and also had concluded that the Ca2+ had entered the endoplasmic reticulum (but see Altin and Bygrave, 1988) . Mine et al. (1988a) examined Ca2+ mobilization in rat hepatocytes loaded with aequorin and concluded that the intracellular Ca2+ pool mobilized by glucagon is different from that mobilized by the vasoactive agents phenylephrine and angiotensin II. This conclusion was based on the observation that brief prior treatment of hepatocytes with dinitrophenol prevented glucagon but not angiotensin II from inducing an increase in cytoplasmic Ca2+. Kraus-Friedmann (1986) had previously shown that glucagon releases Ca2+ from a carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP)-releasable pool.
As implied above, it seems that the experimental conditions can influence the extent to which mitochondria or the endoplasmic reticulum (or both) provide the agonist-sensitive pool of Ca2 . Most workers seem to be of the view, however, that the bulk of this pool is non-mitochondrial.
OTHER Ca2+ FLUX-RELATED SIGNALS GENERATED BY GLUCAGON
During the 1970s a number of reports appeared indicating that administration of glucagon to the intact rat, or to the perfused liver, or to hepatocytes, induced changes in the ability of the subsequently isolated organelle to transport Ca2+ (for reviews see Bygrave, 1978a; Soboll and Sies, 1989) . A large body of work showed, for instance, that administration of glucagon to intact rats will enhance the ability of the subsequently isolated microsomes to accumulate Ca21 in vitro (e.g. Bygrave and Tranter, 1978; Reinhart and Bygrave, 1981; Andia-Waltenbaugh et al., 1981) . With mitochondria too, it was established that prior glucagon administration to the intact rat led to an increased ability of the subsequently isolated organelle to retain Ca2+ (e.g. Prpic et al., 1978) . While it is somewhat unclear how and if these phenomena relate to the control by glucagon of hepatic Ca2+ fluxes, they provide a framework for a more recent set of observations indicating that Ca2+ uptake and release can be modulated by metabolites whose cytosolic concentrations can increase very rapidly following glucagon action. (Benedetti et al., 1988) , and therefore a sensitization by glucagon to Ins(1,4,5)P3-dependent agonists can be envisaged. The effect on the Ins(1,4,5)P3-insensitive Ca2+ pool also could contribute to the termination of the effect of Ins(1,4,5)P3-dependent agonists by reaccumulating released Ca2+ (Benedetti et al., 1986 Lee, 1989) and the increase in acyl-CoA cellular content (Comerford and Dawson, 1993 (1985) examining glucagon-induced Ca2+ fluxes in rat hepatocytes was carried out with 24-h-starved animals and the data appear qualitatively similar to those obtained by others using hepatocytes from fed animals. On the other hand, Rashed and Patel (1987) found that in 24-h-fasted animals, glucagon failed to induce 45Ca efflux, but that induced by phenylephrine was unaffected. They suggested that the cellular redox potential regulates the ability of glucagon to promote Ca2+ efflux, probably through altering the cyclic AMP concentration. It was also reported (Banhegyi et al., 1991) that the synergistic inflow of Ca2+ induced by glucagon and Ca2+-mobilizing agonists was reduced in hepatocytes from fasted rats (as compared to those from fed rats). As in the study of Rashed and Patel (1987) (Benedetti et al., 1985 (Benedetti et al., , 1987 . In this noradrenaline would not increase intracellular [Call] , preCross-talk in liver between glucagon and Ca2+-mobilizing agonists 9 incubation of the cells with glucagon allowed noradrenaline to induce a large increase. This change in sensitivity was interpreted to be correlatable with large increases in binding of noradrenaline to sites on the hepatocyte surface. These workers suggested that a modification by cyclic AMP at the level of the a1-adrenergic receptor mediated this effect. Altin and Bygrave (1986) , making dose-response measurements with the perfused rat liver, observed that the sensitivity of vasopressin and angiotensin (but not so much that of phenylephrine) was apparently increased by the presence of a low glucagon concentration. It should be noted that Poggioli et al. (1986) did not observe an alteration in the sensitivity to the agonists. As found by Morgan et al. (1985) , the increase in sensitivity is such that the concentrations of hormones that are inducing the effects on Ca2l fluxes is well within the physiological range. Buhler et al. (1978) , for example, have analysed the circulating glucagon and noradrenaline concentrations, finding these to be 0.1-0.01 nM. Conditions of severe stress, like some other conditions in vivo, cause a concomitant increase in plasma adrenaline and glucagon (Eigler et al., 1979) . Elevated levels of glucagon in the blood appear to accompany hyperglycaemia in diabetes mellitus (Unson et al., 1989 (1985) showed that the initial rate of 45Ca uptake by hepatocytes was stimulated by glucagon, and Staddon and Hansford (1986) using the Ca2+-free/Ca2+ re-admission technique with fura2-loaded hepatocytes also found that glucagon could stimulate Ca2+ inflow. More recently, Bygrave et al. (1993a) , using the same technique, have confirmed and extended the finding of Staddon and Hansford (1986) to show that the effects of glucagon on Ca2+ inflow are already maximal by 5-10 s after its addition to hepatocytes and therefore are far more rapid in onset than those on mobilization of intracellular Ca2+ pools. In this latter study, dibutyryl cyclic AMP could reproduce the effects on Ca2+ inflow seen with glucagon.
EFFECTORS GENERATED BY GLUCAGON ACTION THAT MIGHT SERVE AS MODULATORS OF Ca2+ FLUXES

POSSIBLE LOCI IN THE SIGNALLING TRANSDUCTION PATHWAYS WHERE CROSS-TALK MIGHT TAKE PLACE AND THE RELATED ISSUE OF WHETHER GLUCAGON IS ABLE TO GENERATE INS(1,4,5)P3 IN THE ABSENCE OR PRESENCE OF Ca2+-MOBILIZING AGONISTS
As we have seen above, there is mounting evidence that practically from the moment of its administration to a suspension of hepatocytes, glucagon itself is able to rapidly induce the mobilization of Ca2 . Such rapidity of action raises the issue of the extent to which cross-talk might be taking place at or near the level of the G proteins that couple receptors to various effector molecules (see Figure 4) , or at points distal to the site of the plasma membrane-located agonist-receptor interactions ( Figure  5 ). It will also have become apparent that one potential mechanism whereby glucagon could influence the action of Ca2+-mobilizing agonists is through altering the ability of the cell to generate Ins(1,4,5)P3.
Earlier studies from a number of laboratories indicated that glucagon alone has no significant effect on Ins(1,4,5)P3 generation in hepatocytes (Prpic et al., 1982; Kaibuchi et al., 1982; Charest et al., 1985b ) and fails to increase Ins(1,4,5)P3 breakdown (Creba and Hansen (1987) showed that glucagon, while enhancing adrenaline-induced Ca2+ inflow in hepatocytes, had no effect on the generation of Ins(1,4,5)P3. Burgess et al. (1986 Burgess et al. ( , 1991 found (like Cocks et al., 1984) that isoprenaline administration to guinea pig hepatocytes caused little, if any, increase in Ins(1,4,5)P3 formation in the absence or presence of angiotensin II.
As will now be discussed, this issue has been re-opened by several sets of data. First, Wakelan et al. (1986) have provided evidence that glucagon is able to activate two signal-transduction systems in hepatocytes depending on the agonist concentrations employed. At low (physiological; Ka approx. 0.25 nM) concentrations, glucagon activates a system that leads to the generation of inositol phosphates and little, if any, cyclic AMP. Adenylate cyclase is activated only at higher concentrations (> 10-9 M) with concomitant production of cyclic AMP. Wakelam et al. (1986) also showed that by 5 s after administration of glucagon to hepatocytes, Ins(1,4,5)P3 is already increased by some 150%, by 10 s it is maximally generated (by some 35 % over basal) and by 30 s it has returned to near-basal levels. The amount of Ins(1,4,5)P3 generated was, however, considerably less than that generated by the action of al-adrenoceptors or by vasopressin.
Secondly, vom Dahl et al. (1988) , working with the perfused rat liver, showed that while vasopressin and glucagon each were able to promote [3H]inositol release from the liver of a rat previously administered [3H]inositol, with vasopressin the response was Li-sensitive but with glucagon it was Li-insensitive.
Thirdly, and consistent with the conclusions of Wakelam et al. (1986) , Mine et al. (1988b) have shown that the cytoplasmic [Ca2+] can be increased following glucagon administration to aequorin-loaded rat hepatocytes, through an action apparently largely independent of cyclic AMP generation. The action of glucagon was very rapid in onset, the response was transient, and the increase in cytoplasmic [Ca2+] was accompanied by only a very small elevation of cyclic AMP. Mine et al. (1988b) concluded that at least part of the action of glucagon on Ca2+ mobilization, especially stimulation of Ca21 inflow, is a process that occurs independently of cyclic AMP generation.
Fourthly, Unson et al. (1989) have described the biological properties of the glucagon antagonist des-His1-[Glu9]glucagon amide. This analogue bound to liver membranes but did not stimulate cyclic AMP production. It did, however, activate a pathway that led to the generation of inositol phosphates. The authors concluded that either there are two distinct glucagon receptors on the hepatocyte plasma membrane, or there is one binding site but two G proteins.
Finally, a group of recent reports have appeared that concern the cloning and expression of the glucagon receptor and other closely related receptors. Jelinek et al. (1993) recently described the cloning, expression and signalling properties of the rat glucagon receptor. The cloned receptor was reported to increase intracellular cyclic AMP following the binding of glucagon. Moreover, and most relevant to the present discussion, it transduced a signal that led to a very rapid elevation (i.e. within seconds) of the cytoplasmic [Ca2+] . Thus the cloned glucagon receptor is able to transduce signals that lead to the accumulation of two different second messengers, cyclic AMP and Ca2 . In a related study, Abou-Samra et al. (1992) reported the cloning and expression of the parathyroid hormone receptor. Upon activation, both adenylate cyclase and phospholipase C were stimulated. This led to intracellular accumulation of cyclic AMP and inositol trisphosphates with concomitant rapid increases in the cytoplasmic [Ca2+] (Abou-Samra et al., 1992) . The calcitonin receptor also has been cloned and expressed (Chabre et al., 1992 Figure 4 Possible Interactions associated with the hepatocyte plasma membrane that might be involved in the cross-talk between the actions of glucagon and agonists that mobilize Ca2+
The interaction of glucagon or the agonist (both indicated by A) with its receptor (R) activates a G protein (shown in 1). This activated G protein, located in the plasma membrane, in turn produces a range of possible effects on the effector molecules shown (see 11) that lead directly or indirectly to modulation of Ca2+ fluxes (indicated by the broken lines). The membrane environment would provide rapid and sensitive interactions without the relatively slow diffusion of generated messengers through the cytoplasmic medium. a, , and y are subunits of the G protein located in the plasma membrane. AC, adenylate cyclase; PLC, phospholipase C; cAMP, cyclic AMP. For further explanation, see the text.
AMP and inositol trisphosphates, again with rapid increases in intracellular [Ca2+] . Thus all three of these closely related receptors are able to be activated in such a way that the individual (single) receptor efficiently couples to multiple effector systems, i.e. those leading to generation of both cyclic AMP and inositol trisphosphates. In the light of this, it is of some interest that Yamaguchi (1991) showed that calcitonin was able to stimulate basal Ca2+ inflow in rat hepatocytes as well as potentiate adrenaline-induced Ca2+ inflow.
All of these observations thus raise the issue of the nature of the locus/loci at which the signals generated by glucagon and by Ca2+-mobilizing agonists interact so as to permit cross-talk. A number of articles have appeared reviewing the evidence for the role of G proteins in signal transduction (see, e.g., Freissmuth et al., 1989; Taylor, 1990; Simon et al., 1991 ; Cockroft and Thomas, 1992; Milligan, 1992) and in coupling to ion channel pathways (Brown, 1991) . What is clear is that G proteins allow for great diversity in signal transduction, acting as switches by being able to rapidly activate or desensitize effector molecules. Moreover, a single receptor can in principle activate multiple G protein molecules, thus amplifying the ligand binding event (Simon et al., 1991) . Similar G proteins may also be able to generate signals with different time constants.
Cross-activation, it has been suggested (Taylor, 1990; Simon et al., 1991) , can be an essential part of the G-protein-mediated information-transducing circuit, co-ordinating and integrating signal cross-talk. In situations where a G protein is closely linked spatially with an ion channel in a membrane, there is an increased likelihood of an increase in the time constant (Brown, 1991) . Thus directly coupled G protein-ion channel pathways have faster time constants and new steady states are reached more quickly.
All of these events can be further modulated in turn by the actions of cyclic AMP-dependent protein kinases and by diacylglycerol and protein kinase C. Phosphorylation of both the G protein receptors and the G proteins themselves (see Brown, 1991) will add to the possibilities for amplification, memory, changes in sensitivity and sharing of pathways in signal transduction (Taylor, 1990) . In this context, the report of Dasso and Taylor (1992) through glucagon action is metabolized by cyclic AMP phosphodiesterases and the degree to which adenylate cyclase itself is activated/desensitized (Houslay et al., 1992) . Another factor having a potentially critical bearing on this is the extent to which intracellular cyclic AMP is free or is bound to intracellular ligands (see, e.g., Sammak et al., 1992) . Many of these points are collected together in the scheme shown in Figure 4 . Two further points can now be made concerning the locus/loci at which signalling cross-talk occurs. The first is that it is clear that cyclic AMP can potentiate Ca2+ mobilization induced by Ca2+-mobilizing agonists at loci distal to the point at which the second messengers are generated (see Figure 5 ). It is also clear that in the bulk of the experiments showing this, a relatively long time (> 60 s) was usually allowed to elapse between additions of glucagon/dibutyryl cyclic AMP/forskolin and the Ca2+-mobilizing agonist. It is possible that the rapid responses to glucagon action (i.e. those occurring within say 5 s) may result not from the generation of cyclic AMP, but from the generation of Ins(1,4,5)P3 or some other, as yet unidentified, factor. Thus not only could the glucagon concentration used be important in determining the second messenger produced, but also the time at which measurements are made may have an effect: longer times of glucagon action may provide information different to that produced at shorter times, especially considering the rapid turnover of Ins(1,4,5)P3 generated by low glucagon concentrations (Wakelam et al., 1986 (Altin and Bygrave, 1986; Poggioli et al., 1986; Mauger and Claret, 1988; Kass et al., 1990) have expressed the view that the synergistic action of glucagon and Ca2+-mobilizing agonists occurs close to Ca2l channels or on the carriers themselves located at the plasma membrane. The suggestions are that control might be effected through cyclic AMP perhaps phosphorylating Ca2+ channels and/or (Poggioli et al., 1986) The other possibility, that cross-talk occurs at or before hormone-induced phosphatidylinositol metabolism, has been proposed by Blackmore and Exton (1986) . The results of their experiments, in which the effects of 4,-phorbol 12-myristate 13-acetate and aluminium fluoride on Ca2+ mobilization in rat hepatocytes were examined, led them to suggest that the mobilization of Ca2+, induced by glucagon, results from cyclic AMPdependent phosphorylation of Np, phosphatidylinositol bisphosphate, or the event leading to Ins(1,4,5)P3formation.
In contrast to some of the reports mentioned above, Pittner and Fain (1989) observed a synergistic increase of Ins(1,4,5)P3 formation when bromocycic AMP was administered to rat hepatocytes with vasopressin. They suggested, not dissimilar to Blackmore and Exton (1986) , sites of action of elevated cyclic AMP as possibly being one or other of the vasopressin receptor, the Gp (Np) protein or the phospholipase C enzyme itself.
While not directly related to the issue of the mechanism of synergism between glucagon and agonist-induced Ca2+ mobilization, it is relevant to point out that Hughes et al. (1987) reported that a GTP-binding protein is involved in the process by which vasopressin and EGF stimulate receptor-operated Ca2+ inflow transporters (see also Barritt and Hughes, 1991) . EGF does not increase Ins(1,4,5)P3 formation, and pertussis toxin treatment (which blocks the action of G proteins) of rat hepatocytes abolished EGF-and vasopressin-induced Ca2+ inflow. Also relevant are the reports showing that 4fl-phorbol 12-myristate 13-acetate treatment of hepatocytes, which leads to activation of protein kinase C, attenuates the Ca2+-mobilizing action of glucagon (Staddon and Hansford, 1986 ; see also Garcia-Sainz et al., 1985; Staddon and Hansford, 1989; Pittner and Fain, 1991) . Whether some of the signals being generated here result from hormone-induced phosphatidylcholine breakdown (Exton, 1990) remains an interesting possibility.
CONCLUDING REMARKS AND FUTURE DIRECTIONS
This review has considered a number of observations, obtained from studies both with the whole organ (perfused rat liver) and with hepatocytes isolated therefrom, concerning the interaction of the second messenger-mediated signalling systems originating at the plasma membrane and for which glucagon and Ca2+-mobilizing agonists are the stimuli. A number of experimental approaches and techniques, combined with the deployment of a range of pharmacological agents, have already been brought into play to examine the signalling cross-talk phenomenon. Apart from the perfused rat liver system, these include the increasingly widespread use of single-cell systems to examine the influence of various hormone regimes on Ca2+ mobilization in oscillatory phenomena (e.g. Schofl et al., 1991) , in computer-assisted mathematical modelling (e.g. Somogyi and Stucki, 1991) and following the application of microinjection techniques (e.g. Glennon et al., 1992) . All of these approaches will continue to provide relevant information and, in combination with the cloning techniques now available, results of some of which were mentioned above, exciting new insights into signalling cross-talk are assured. Two other recent developments with great potential for the present study are noteworthy. One is the ability to express a Ca2+-mobilizing receptor, such as the V1-vasopressin receptor cloned from rat liver, in Xenopus oocytes (Nathanson et al., 1992) and to then examine the subcellular distribution of Ca2+ signals by confocal microscopy following activation of the receptor. A chondria and observe the changes specifically in mitochondrial [Ca2l] in response to various stimuli (Rizzuto et al., 1992) . No doubt all of this will be further aided by the development of even more diverse indicators including those designed to measure rapid changes in intracellular cyclic AMP (Tsien, 1992; Sammak et al., 1992) .
While each of the experimental systems (whole organ and single cells) offers particular attributes to investigations of crosstalk, there is a remarkable similarity and confluence among the data already obtained. The integration of the information gained from each is providing considerable information in turn about the nature of the synergistic response. The view previously expressed in a number of reports, i.e. that enhanced mobilization and especially Ca2l inflow is a major target for cross-talk between these signalling systems, has been reinforced. An interesting facet of hormone-induced Ca2l inflow, not often considered, is that irrespective of what combination of hormones is present, Ca2+ inflow will not take place unless a substantial Ca2+ gradient exists across the plasma membrane.
The major features of the synergism so far revealed (see Figure  5 ) are (1) that it can occur at very low (physiological) concentrations of each of the two sets of hormones, (2) that responses are able to be induced which are very rapid in onset, and (3) that the earliest response, which is practically immediate, appears to be Ca2+ inflow; only after some 30 s is glucagon able to mobilize Ca2+ apparently from the same internal Ca2+ store as that mobilized by vasopressin; this is non-mitochondrial and most probably endoplasmic reticular in origin. Just as there appear to be Ins(1,4,5)P3-sensitive and -insensitive Ca2+ pools in the endoplasmic reticulum, so one might also envisage glucagonsensitive and -insensitive pools in the same organelle, all of which are in some way functionally interactive.
Despite these revelations, the mechanism by which cross-talk between the two second messenger-mediated signalling systems occurs to bring about the potentiation in Ca2+ mobilization is still largely unknown. Data from a number of separate reports, all examining different aspects of glucagon action as well the molecular biology of the glucagon and other closely related receptors, provide strong evidence for Ca2+ mobilization induced by glucagon alone. This apparently occurs not through the generation of cyclic AMP, but rather through the generation of Ins(1,4,5)P3, albeit at lower concentrations than those generated by 'classical' Ca2+-mobilizing agonists such as a1-adrenergic agonists, vasopressin and angiotensin. The extent to which this action of glucagon (at low concentrations) contributes to the cross-talk phenomenon remains to be addressed, as does the question of whether this in turn is a component of the mechanism by which glucagon mobilizes Ca2+ from intracellular Ca2+ stores. Recent findings that activation of the cloned glucagon receptor results in Ca2+ mobilization independent of cyclic AMP production but with generation of Ins(1,4,5)P3 is particularly intriguing and raises the question of the extent to which G proteins might play a part in cross-talk.
Suggested intracellular sites of action of glucagon are the Ca2+ transporters in mitochondria (Morgan et al., 1985) , in the endoplasmic reticulum (Burgess et al., 1986; Mauger et al., 1989) and in the plasma membrane (Poggioli et al., 1986; Altin and Bygrave, 1986; Kass et al., 1990) . It is possible that all sites are modified but perhaps to different extents and at different times following glucagon administration. Whilst glucagon action is known to be able to lead to the phosphorylation of cytoplasmic proteins (Garrison and Borland, 1977) including the multifunctional Ca2+/calmodulin-dependent protein kinase (Connelly et al., 1987) as well as membrane proteins (Vargas et al., 1982), second is the ability to target recombinant aequorin into mitoit is not yet established if any of these are components of, or are Cross-talk in liver between glucagon and Ca2+-mobilizing agonists in any way associated with, the above-mentioned Ca2+ transport systems. Presumably details about possible phosphorylation events will become clearer once the molecular architecture of these Ca2+ transporters/channels becomes known.
Another area of recent study in which the outcome is of potential interest is the hormonal regulation of the Ins(1,4,5)P3 receptor. It is known that the receptor can be phosphorylated by a cyclic AMP-dependent protein kinase resulting in a decrease in the ability of Ins(1,4,5)P3 to release Ca2+ from microsomal stores (Ferris et al., 1991) . It has been suggested (Mauger et al., 1989) that in liver such a mechanism could participate in the synergistic action of cyclic AMP and Ins(1,4,5)P3-dependent hormones on Ca2+ mobilization. The extent to which this occurs remains to be assessed.
Finally, one might well question the physiological significance of the cross-talk phenomenon in liver. Clearly much of the current research in liver is focused on mechanisms at the cellular and subcellular level. A role for cross-talk between second messenger-generated signalling systems leading to modulated Ca2+ fluxes is seen to be crucial, for instance in excitationcontraction coupling in cardiac (see, e.g., Cohen, 1992) and smooth muscle (see, e.g., Abdel-Latif, 1991) cells, and in the rapid secretion of insulin (e.g. Holz and Habener, 1992) and saliva (e.g. McKinney et al., 1989) , all of which are well established Ca2+-dependent phenomena. We envisage that one of the roles of cross-talk between the two signalling systems in liver, described in this review, is to amplify and/or sensitize signals of which Ca2+ is a vital component. One physiological function in liver recognized only very recently as being subject to rapid, short-term modulation by glucagon and Ca2+-mobilizing hormones is bile secretion (Bygrave et al., 1993b) . This group has found that the ability of vasopressin to rapidly (in a time-frame of seconds) alter bile flow in the perfused rat liver is greatly modified when glucagon is preadministered also for only a brief time (Hamada et al., 1992a ). This synergistic response, which is induced by physiological concentrations of the agonists, can be modulated in turn by the action of cholestatic and choleretic bile salts administered in vitro (Hamada et al., 1992b) and by agents that induce cholestasis in vivo (Bygrave et al., 1993b) . All of these features should provide a useful set of probes with which one can gain further insights in liver, into a genuine physiological system modulated by cross-talk between the actions of glucagon and Ca2+-mobilizing agonists.
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